Do-Over

It's no secret that the pharmaceutical industry is struggling — R&D budgets are being slashed and companies are relying more on acquisitions than innovation to replenish their pipelines. In a Forbes column, Steve Denning says that if big pharma wants to survive, it has to retool. Companies like Apple and Amazon have proven that a mature industry needs imagination to grow, Denning says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.